论文部分内容阅读
目的观察丹红注射液治疗脑卒中恢复期瘀血闭阻证的临床疗效及其安全性。方法选择符合诊断标准的脑卒中恢复期患者68例,随机分为治疗组37例,给予丹红注射液治疗;对照组31例,给予舒血宁注射液治疗。14d为1个疗程,在给药1周、2周后分别进行神经功能缺损(NIHSS)、日常生活能力(BI)、中医证候、脑卒中疗效及安全性评定,进行统计学分析。结果治疗组和对照组NIHSS、BI较治疗前均有大幅度的提高,治疗效果无显著差异。结论丹红注射液治疗脑卒中恢复期瘀血闭阻证安全、有效,整体疗效与舒血宁注射液相当。
Objective To observe the clinical efficacy and safety of Danhong injection in treating blood stasis obstruction during recovery from stroke. Methods Sixty-eight patients with convalescent stroke who meet the diagnostic criteria were randomly divided into treatment group (37 cases) and Danhong injection (control group). Shuxuening injection was given in 31 cases in control group. 14d for a course of treatment, in the administration of 1 week, 2 weeks after the neurological deficit (NIHSS), daily living ability (BI), TCM Syndrome, stroke efficacy and safety assessment, statistical analysis. Results The NIHSS and BI in the treatment group and the control group were significantly increased compared with that before treatment, and the treatment effect was not significantly different. Conclusion Danhong injection in the recovery of blood stasis during the recovery of closed obstructive card is safe and effective, the overall effect and Shuxuening injection equivalent.